Absence of an osteopetrosis phenotype in IKBKG (NEMO) mutation-positive women: A case- control study

被引:4
作者
Frost, Morten [1 ,2 ,3 ]
Tencerova, Michaela [3 ]
Andreasen, Christina M. [4 ,5 ]
Andersen, Thomas L. [5 ]
Ejersted, Charlotte [3 ]
Svaneby, Dea [6 ]
Qui, Weimin [3 ]
Kassem, Moustapha [3 ]
Zarei, Allandad [9 ]
McAlister, William H. [7 ]
Veis, Deborah J. [8 ,9 ]
Whyte, Michael P. [8 ,9 ]
Frederiksen, Anja L. [1 ,10 ]
机构
[1] Univ Southern Denmark SDU, Fac Hlth, Dept Clin Res, Winslowpk 19-3, DK-5000 Odense C, Denmark
[2] OUH, Steno Diabet Ctr Odense, JB Winslows Vej 4, DK-5000 Odense C, Denmark
[3] OUH, Mol Endocrinol Unit, Dept Endocrinol, JB Winslows Vej 4, DK-5000 Odense C, Denmark
[4] OUH, Dept Orthopaed Surg & Traumatol, Orthopaed Res Lab, JB Winslows Vej 15, DK-5000 Odense C, Denmark
[5] Vejle Hosp, Dept Clin Cell Biol, Beridderbakken 4, DK-7100 Vejle, Denmark
[6] Vejle Hosp, Dept Clin Genet, Beridderbakken 4, DK-7100 Vejle, Denmark
[7] Washington Univ, St Louis Childrens Hosp, Dept Pediat Radiol, Mallinckrodt Inst Radiol,Sch Med, St Louis, MO 63110 USA
[8] Shriners Hosp Children, Ctr Metab Bone Dis & Mol Res, St Louis, MO USA
[9] Washington Univ, Sch Med, Dept Internal Med, Barnes Jewish Hosp,Div Bone & Mineral Dis, St Louis, MO 63110 USA
[10] Odense Univ Hosp, Dept Clin Genet, JB Winslows Vej 4, DK-5000 Odense C, Denmark
关键词
NEMO; IKBKG; NF-kappa B; Osteopetrosis; X-chromosome inactivation; Incontinentia pigmenti; NF-KAPPA-B; X-CHROMOSOME INACTIVATION; HYPOHIDROTIC ECTODERMAL DYSPLASIA; INCONTINENTIA-PIGMENTI; BONE-FORMATION; OSTEOBLAST DIFFERENTIATION; OSTEOCLAST FORMATION; SOMATIC MOSAICISM; REVERSAL-CELLS; MALE INFANT;
D O I
10.1016/j.bone.2019.01.014
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: NF-kappa B essential modulator (NEMO), encoded by IKBKG, is necessary for activation of the ubiquitous transcription factor nuclear factor kappa-light-chain-enhancer of activated B cells (NF-kappa B). Animal studies suggest NEMO is required for NF-kappa B mediated bone homeostasis, but this has not been thoroughly studied in humans. IKBKG loss-of-function mutation causes incontinentia pigmenti (IP), a rare X-linked disease featuring linear hypopigmentation, alopecia, hypodontia, and immunodeficiency. Single case reports describe osteopetrosis (OPT) in boys carrying hypomorphic IKBKG mutations. Method: We studied the bone phenotype in women with IP with evaluation of radiographs of the spine and non dominant arm and leg; lumbar spine and femoral neck aBMD using DXA; mu-CT and histomorphometry of trans iliac crest biopsy specimens; bone turnover markers; and cellular phenotype in bone marrow skeletal (stromal) stem cells (BM-MSCs) in a cross-sectional, age-, sex-, and BMI-matched case-control study. X-chromosome inactivation was measured in blood leucocytes and BM-MSCs using a PCR method with methylation of HpaII sites. NF-kappa B activity was quantitated in BM-MSCs using a luciferase NF-kappa B reporter assay. Results: Seven Caucasian women with IP (age: 24-67 years and BMI: 20.0-35.2 kg/m(2)) and IKBKG mutation (del exon 4-10 (n = 4); c.460C > T (n = 3)) were compared to matched controls. The IKBKG mutation carriers had extremely skewed X-inactivation ( > 90:10%) in blood, but not in BM-MSCs. NF-kappa B activity was lower in BM-MSCs from IKBKG mutation carriers (n = 5) compared to controls (3094 +/- 679 vs. 5422 +/- 1038/mu g protein, p < 0.01). However, no differences were identified on skeletal radiographics, aBMD, mu-architecture of the iliac crest, or bone turnover markers. The IKBKG mutation carriers had a 1.7-fold greater extent of eroded surfaces relative to osteoid surfaces (p < 0.01), and a 2.0-fold greater proportion of arrested reversal surface relative to active reversal surface (p < 0.01). Conclusion: Unlike mutation-positive males, the IKBKG mutation-positive women did not manifest OPT.
引用
收藏
页码:243 / 254
页数:12
相关论文
共 65 条
[1]   Inhibition of osteoblast differentiation but not adipocyte differentiation of mesenchymal stem cells by sera obtained from aged females [J].
Abdallah, Basem M. ;
Haack-Sorensen, Mandana ;
Fink, Trine ;
Kassem, Moustapha .
BONE, 2006, 39 (01) :181-188
[2]   Phenotypic severity of autosomal dominant osteopetrosis type II (ADO2) mice on different genetic backgrounds recapitulates the features of human disease [J].
Alam, Imranul ;
McQueen, Arnie K. ;
Acton, Dena ;
Reilly, Austin M. ;
Gerard-O'Riley, Rita L. ;
Oakes, Dana K. ;
Kasipathi, Charishma ;
Huffer, Abigail ;
Wright, Weston B. ;
Econs, Michael J. .
BONE, 2017, 94 :34-41
[3]  
ALLEN RC, 1992, AM J HUM GENET, V51, P1229
[4]   Suppression of NF-κB Increases Bone Formation and Ameliorates Osteopenia in Ovariectomized Mice [J].
Alles, Neil ;
Soysa, Niroshani S. ;
Hayashi, Juri ;
Khan, Masud ;
Shimoda, Asako ;
Shimokawa, Hitoyata ;
Ritzeler, Olaf ;
Akiyoshi, Kazunari ;
Aoki, Kazuhiro ;
Ohya, Keiichi .
ENDOCRINOLOGY, 2010, 151 (10) :4626-4634
[5]   Understanding Coupling between Bone Resorption and Formation Are Reversal Cells the Missing Link? [J].
Andersen, Thomas L. ;
Abdelgawad, Mohamed E. ;
Kristensen, Helene B. ;
Hauge, Ellen M. ;
Rolighed, Lars ;
Bollerslev, Jens ;
Kjaersgaard-Andersen, Per ;
Delaisse, Jean-Marie .
AMERICAN JOURNAL OF PATHOLOGY, 2013, 183 (01) :235-246
[6]   A reversal phase arrest uncoupling the bone formation and resorption contributes to the bone loss in glucocorticoid treated ovariectomised aged sheep [J].
Andreasen, Christina M. ;
Ding, Ming ;
Overgaard, Soren ;
Bollen, Peter ;
Andersen, Thomas L. .
BONE, 2015, 75 :32-39
[7]   The NF-kappa B and I kappa B proteins: New discoveries and insights [J].
Baldwin, AS .
ANNUAL REVIEW OF IMMUNOLOGY, 1996, 14 :649-683
[8]  
Baron R., 1977, Toulouse, P179
[9]   Resveratrol inhibits myeloma cell growth, prevents osteoclast formation, and promotes osteoclast differentiation [J].
Boissy, P ;
Andersen, TL ;
Abdallah, BM ;
Kassem, M ;
Plesner, T ;
Delaissé, JM .
CANCER RESEARCH, 2005, 65 (21) :9943-9952
[10]   Incontinentia pigmenti in a Male Infant with Klinefelter Syndrome: A Case Report and Review of the Literature [J].
Buinauskaite, Evelina ;
Buinauskiene, Jurate ;
Kucinskiene, Vesta ;
Strazdiene, Dale ;
Valiukeviciene, Skaidra .
PEDIATRIC DERMATOLOGY, 2010, 27 (05) :492-495